TNF and rheumatoid arthritis: Whilst such approaches have been very effective for certain diseases [e.g., anti-TNF-α monoclonal antibodies for the treatment of rheumatoid arthritis (RA)] a large percentage of patients either do not respond to treatment or become refractory to therapeutic antibody treatment (4, 5).